Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: A Systematic Review.

Shalata, Walid; Abu-Salman, Amjad; Steckbeck, Rachel; Mathew Jacob, Binil; Massalha, Ismaell; Yakobson, Alexander

Shalata, Walid; Abu-Salman, Amjad; Steckbeck, Rachel; Mathew Jacob, Binil; Massalha, Ismaell; Yakobson, Alexander.

Affiliation

Shalata W; The Legacy Heritage Center & Dr. Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.
Abu-Salman A; Cardiology Division, Soroka Medical Center, Beer Sheva 84105, Israel.
Steckbeck R; Medical School for International Health, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
Mathew Jacob B; Medical School for International Health, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
Massalha I; The Legacy Heritage Center & Dr. Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.
Yakobson A; The Legacy Heritage Center & Dr. Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.

Cancers (Basel) ; 13(20)2021 Oct 18.

Article in En | MEDLINE | ID: mdl-34680365

Key words

cardiac toxicity; cardiotoxicity; cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) inhibitors; immune checkpoint inhibitors (ICIs); immune-related adverse events (IRAE); programmed cell death protein 1 (PD-1); programmed death-ligand 1 (PD-L1)

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies / Systematic_reviews Language: En Journal: Cancers (Basel) Year: 2021 Document type: Article

Fulltext

XML

PubMed Links

Search on Google